Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01159327
Recruitment Status : Terminated (low enrolling participants)
First Posted : July 9, 2010
Last Update Posted : November 11, 2015
Information provided by (Responsible Party):
Ji-youn Han, National Cancer Center, Korea

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2013
  Actual Study Completion Date : June 2013